|
|
||||||||
From the Department of Ophthalmology, Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon.
| Abstract |
|---|
|
|
|---|
METHODS. Human trabecular meshwork cell cultures were established from six young donors. A cDNA library was made from the combined trabecular meshwork mRNA. The end-sequence of random clones was determined by direct sequencing. These sequences were then analyzed by a National Center for Biotechnology Information (NCBI, Bethesda, MD) database search. Nucleotide searches were performed using the BLASTN (ver. 2.1.3; against the nonredundant nucleic acid sequence) and dbEST databases (both provided by NCBI in the public domain at www.ncbi.nlm.nih.gov).
RESULTS. Sequences from 1118 clones from this nonamplified trabecular meshwork cDNA library were categorized. Of these, 877 expressed sequence tags (ESTs) (78.7%) were known genes. One hundred thirty-nine ESTs (12.5%) showed close identity to EST sequences reported in the public domain database (dbEST). Thirteen ESTs (1.2%) showed no significant similarity to known genes or ESTs in the public databases and were thus defined as novel ESTs. The most abundant genes expressed by the human trabecular meshwork included ferritin H, eukaryotic translation elongation factor 1-
, ferritin L, fibronectin, and TIMP-1. Ferritin H was the most abundant transcript, making up more than 4% of the genes expressed by the human trabecular meshwork. Extracellular matrix proteins were also highly expressed. The chromosome location of the trabecular meshwork ESTs is reported.
CONCLUSIONS. A profile of genes expressed by human trabecular meshwork is presented. Thirteen novel ESTs were identified. The combined information obtained from expression analysis and chromosomal localization of trabecular meshwork cDNAs should be valuable in identifying candidate genes for glaucoma.
| Introduction |
|---|
|
|
|---|
Primary open-angle glaucoma (POAG) is one of the leading causes of blindness in the industrialized world.5 A disease of the elderly, POAG will have a major impact on the quality of life of a population that is rapidly aging. The pathophysiology of POAG is not well understood. Six POAG genes have been mapped6 7 8 9 10 11 12 and two of these have been identified, MYOC (GLC1A) and OPTN (GLC1E).13 14 Developing better therapeutic strategies for this major blinding disease depends on breakthroughs in understanding the pathophysiology of POAG.
To identify the molecules expressed specifically in the human trabecular meshwork, we used a method called expression profiling of active genes. This method entails sequencing randomly selected clones from a 3'-directed cDNA library that faithfully represents the original composition of mRNA species.15 The active genes are then identified by their sequences, and the relative abundance of each transcript can be estimated by the frequency of the corresponding EST in the cDNA library. The resultant gene expression profile provides a quantitative estimate of the profile of the relative transcript abundance in human trabecular meshwork. This approach is very useful in the identification of cell tissue-typespecific genes by comparing the expression profiles obtained with those from other cell and tissue types.16 17
This is the first analysis of a profile of gene expression in a human trabecular meshwork cell line to be reported. In this study, human trabecular meshwork cell lines from infant donors (age range, 02 years) were combined to prepare a cDNA library. An expression profile of the human trabecular meshwork was obtained. Identification of these human trabecular meshwork genes will help in developing a framework for characterizing gene expression in the normal trabecular meshwork. Candidate POAG genes (GLC1) were identified.
| Materials and Methods |
|---|
|
|
|---|
The human cDNA library was made from mRNA isolated from trabecular meshwork cells established from eyes of six individuals, aged 2 weeks to 2 years. These cell cultures were initiated and maintained in medium with 10% fetal calf serum, as described earlier.18
Confluent cells were harvested at passages 3 through 6. The cells were trypsinized, neutralized with media, flash frozen in liquid N2 and stored at -70°C. The frozen cells (
96 x 106) were shipped on dry ice to Invitrogen (San Diego, CA) where a unidirectional cDNA library was constructed by using a pcDNA3 vector and TOP10F' host cells. The isolated mRNA was reverse transcribed with an oligo-dT primer. To make the library unidirectional, the inserts were cut with the restriction enzymes BstXI for the 5' end and NotI for the 3' end. The size of the inserts ranged from 0.5 to 1.6 kb, with the average size being 0.85 kb.
Template Preparation and Sequencing
Plasmid purifications were performed with one of three kits (Mini-prep 24 deom McConnell Research, San Diego, CA; the QIAwell 8 ultra plasmid kit from Qiagen, Valencia, CA; or the Perfectprep Plasmid Mini Kit from Eppendorf, Westbury, NY). The purified plasmid preps were then sequenced on an automated sequencer (model 377; Applied Biosystems, Foster City, CA) at the Molecular Microbiology and Immunology (MMI) Research Core Facility, Oregon Health and Sciences University, or the Veterans Administration Medical Center Molecular Biology Core Laboratory (Portland, OR) using the T7 primer. Because the trabecular meshwork cDNA library is unidirectional, all the ESTs were sequenced from the 5' end of the cDNA clones.
Sequence Analysis
Nucleotide searches were first performed using BLASTN (ver. 2.1.3; unless otherwise noted databases used as resources in this study are provided in the public domain by the National Center for Biotechnology Information [NCBI], Bethesda, MD, and are available at the Internet addresses shown, in this case: http://www.ncbi.nlm.nih.gov/BLAST/) against the nonredundant nucleic acid sequence database. Matching sequences with an Expect (E)-value equaling zero were identified as known genes. Sequences with E-values close to zero, were manually analyzed for sequencing errors, alternative splicing, chimeric clones or contamination with vector sequences.
DNA sequences with no matches in the nonredundant GenBank database (http://www.ncbi.nlm.nih.gov/GenBank/) were subjected to a second search with BLASTN against the dbEST (http://www.ncbi.nlm.nih.gov/dbEST/) database. The dbESTs identified were searched for in the Unique Human Gene Sequence Collection database (UniGene; http://www.ncbi.nlm.nih.gov/UniGene/) to determine whether they had been placed in a gene cluster. BLAST searches were performed between September 2000 and September 2001. All the clones that had been identified as ESTs or unknown genes were BLASTed between August and September 2001. GeneRIF (http://www.ncbi.nlm.nih.gov/LocusLink/) was used to identify the functional role of each gene. Some genes had more than one function, and these were placed in one functional classification to avoid confusion.
The sequences of the 1118 cDNA clones were each mapped by BLASTing the sequences with BLASTN against the human genome database. Chromosome locations were also identified in UniGene, and more than 99% agreement was found between the two methods. Sequence data from this article has been deposited with the European Molecular Biology Laboratory (EMBL) and GenBank Data Libraries (the European Molecular Biology Laboratory library is available in the public domain at http://www.embl-heidelberg.de/).
Semiquantitative RT-PCR Analysis of IGFBP-5, -6, and -7
Human trabecular meshwork cDNA was harvested from infant human trabecular meshwork cell cultures containing 10% fetal calf serum. Isolation of mRNA and reverse transcription of the mRNA was performed, as described previously.19
PCR amplification was performed in a final volume of 25 µL containing 10 mM Tris-HCl (pH 8.3); 50 mM KCl; 1.5 mM MgCl2; 0.001% gelatin; 10 pmol of each primer; 200 µM of dATP, dCTP, dGTP, dTTP; 5 ng of trabecular meshwork cDNA; and 1.0 U Taq polymerase (REDTaq; Sigma, St. Louis, MO) using a commercial PCR system (model 9700; Applied Biosystems) with initial denaturation of 94°C for 10 seconds, 70°C to 60°C for 20 seconds, and 72°C for 40 seconds; 23 cycles of 94°C for 10 seconds, 55°C for 20 seconds, and 72°C for 40 seconds; and a final incubation at 72°C for 5 minutes. The PCR primers used to amplify each of the specific IGFBP mRNAs are shown in Table 1
.
|
Identification of Glaucoma Candidate Genes
The genomic locations of the trabecular meshwork cDNA clones were identified as described above. If a clone mapped to chromosomes 2, 3, 8, or 7 (GLC1B, GLC1C, GLC1D, or GLC1F, respectively), the contig containing that sequence was noted in our database. The initial Human Genome Database sequencing the entire human genome was completed after the GLC1 genes were mapped.20
21
With this new sequence data, the flanking markers of each of the GLC1 loci were identified in their respective contigs and the contigs encompassing each GLC1 locus were aligned. The contigs containing sequences from the trabecular meshwork clones were then compared with the GLC1 contigs. If a contig containing a gene identified by a trabecular meshwork clone was also in a GLC1 contig, then the gene was considered to be a glaucoma candidate gene.
A second method used to determine whether a trabecular meshwork EST was a glaucoma candidate gene was to identify the GLC1 cytogenetic location using the Online Mendelian Inheritance in Man (OMIM) Morbid Map (http://www.ncbi.nlm.nih.gov/Omim/searchmorbid/). LocusLink was then queried with the genes accession number to determine whether the gene was within the GLC1 region as specified by the OMIM Morbid Map.
| Results |
|---|
|
|
|---|
|
Unknown Human Trabecular Meshwork Genes
Of the 1118 clones sequenced, 137 (12.3%) produced sequences matching ESTs from unknown genes previously reported in the dbEST databank. A listing of these ESTs is also available online (see "ESTs from Unknown Genes in the Trabecular Meshwork Library" at http://www.iovs.org/cgi/content/full/43/12/3698/DC1). UniGene clusters have been established for 122 of these ESTs. The number of ESTs in each of these clusters is shown in the online listing of ESTs from unknown genes. The ESTs are sorted by their abundance in UniGene. The ESTs not matching UniGene clusters are shown at the bottom of the table. Sixteen of these clones matched an EST in dbEST but have no UniGene cluster. The remaining 13 clones were unique sequences not found in BLASTN, dbEST, or UniGene, which implies that these genes are expressed only in trabecular meshwork or are very rare transcripts that have not been found in previous EST projects. All the unknown genes were relatively rare trabecular meshwork transcripts, with only one or two clones being found. The majority (91.5%) of the unknown human trabecular meshwork sequences have been mapped. Thus, ESTs that were GLC candidate genes were established.
Highly Expressed ESTs
The ESTs more highly represented (by six or more clones) in the human trabecular meshwork library are summarized in a listing of highly expressed genes (Table 3)
. The three most abundant transcripts are ferritin H, eukaryotic translation elongation factor 1-
, and ferritin L chain. Ferritin H comprises 4.28% of the clones in the human trabecular meshwork library. ESTs shared with the organ culture human trabecular meshwork cDNA library23
are indicated by asterisks. Of the 17 highly expressed genes, 7 were also present in the organ culture trabecular meshwork cDNA library.23
|
Insulin-like Growth FactorBinding Proteins
Most of the known insulin-like growth factor binding proteins (IGFBPs)25
were expressed in the human trabecular meshwork cDNA library. Two of the IGFBPs were highly expressed: IGFBP7 and IGFBP2 (Table 3)
. Lower amounts of IGFBP4, IGFBP5, IGFBP6, and IGFBP8 were present. To determine whether the number of clones reflects the abundance of mRNA in the human trabecular meshwork, RT-PCR of IGFBP7, IGFBP6, and IGFBP5 was performed. All three IGFBP messages were present (Fig. 1)
. The quantity of IGFBP7 mRNA appeared to be at least two to four times higher than IGFBP6 and IGBP5 mRNAs, reflecting the fourfold increase in IGFBP7 found in the trabecular meshwork cDNA library.
|
|
| Discussion |
|---|
|
|
|---|
Characterization of ESTs Present in Normal Human Trabecular Meshwork Cell Lines
The trabecular meshwork morphology is still developing in the period after birth up to 4 years of age.35
Thus, the cell lines, which were established from individuals aged 2 weeks to 2 years may represent a transitional stage with some fundamental differences in gene expression compared with adult cells. Of note, the two major transcripts in our cDNA library were also the two major transcripts in a mouse blastocyst cDNA library.36
Glaucoma Genes
The transcript for myocilin, the GLC1A gene, was not observed in the sequenced clones. This is not unexpected, because myocilin is expressed at low levels in trabecular meshwork cell lines, unless they have been stressed or induced with glucocorticoids.26
27
28
29
30
Candidate genes for GLC1B, GLC1C, GLC1D, and GLC1F were identified. Hepatocellular carcinoma-associated antigen 112 has been analyzed in affected members of GLC1F; however, no disease-causing mutations have been found. We are in the process of analyzing the remaining GLC1C and GLC1F candidate genes in affected family members. PITX2, the RIEG1 gene, was expressed in our library.31
32
33
Abundant Human Trabecular Meshwork Transcripts
The most abundantly expressed transcript in the human trabecular meshwork library was ferritin H, representing 4.28% of the library clones sequenced. The ferritin L gene was the third highest expressed in the trabecular meshwork library. Ferritin is the major iron storage protein of eukaryotes and appears to be ubiquitously expressed.37
The ferritin protein is a spherical shell composed of 24 subunits of varying proportions of H and L chains, depending on the tissue type.38
H-rich ferritin predominates in erythropoietic tissues, where iron availability is required both for heme synthesis and host defense. Ferritin H accumulates and releases iron faster than L-rich ferritin.38
For long-term iron storage in the liver and spleen, L-rich ferritin is the preferred form. The human trabecular meshwork cells were cultured in 10% fetal calf serum, which is rich in iron. The levels of ferritin H transcripts may result from exposure of the cells to a high concentration of iron and/or serum, because both are known to induce synthesis of ferritin H.39
Potential functions for ferritin in the anterior chamber may include providing iron to apoenzymes, boosting host defense and neutralization of oxidative stress by the trabecular meshwork. Myocilin (GLC1A) may be a heat shock or oxidative stress protein. The similar role of ferritin H in macrophages during oxidative stress suggests that, under certain environmental stresses, ferritin H and myocilin may both be important in protecting the trabecular meshwork from reactive radicals. Numerous heat shock proteins, including
B crystallin, HSPB1, HSPA5, HSPCA, and chaperonin were found in the trabecular meshwork library in relatively abundant numbers.
Ferritin was not as highly expressed in the human trabecular meshwork library synthesized from organ culture message,23 although ferritin L was an abundant transcript. This difference between the two human trabecular meshwork libraries could either reflect cell culture versus organ culture, the age difference between the samples, or serum versus serum-free conditions. The ratio of H to L chains varies during development.38 40 Our cDNA library is from cells from infants in whom the trabecular meshwork is still maturing, which may be why this ratio is observed.
Another gene, known for its role in protecting motoneurons from iron toxicity, macrophage inhibitory cytokine-1, was expressed in the trabecular meshwork library.41
IGFBP7 and IGFBP2 were highly expressed in the trabecular meshwork cDNA library, with eight and six clones, respectively. Lower expression of IGFBP5, IGFBP6, IGFBP8, and IGFBP4 was observed. In an earlier article, we described the expression of IGFBP5 in trabecular meshwork.42 In the organ culture human trabecular meshwork, IGFBP3 and IGFBP5 were expressed.23 Thus, all the known IGFBPs with the exception of IGFBP1 have been shown to be expressed in human trabecular meshwork.
Gene Expression and Mechanisms of Trabecular Meshwork Outflow
The trabecular meshwork has been implicated as the site of obstruction of aqueous outflow, which in turn leads to increased intraocular pressure and potentially to glaucoma.4
43
44
Several of the genes expressed in our trabecular meshwork library have been explored by us and others as possible modifiers of aqueous outflow through the trabecular meshwork. Interleukin-1ß, which appears to mediate the response of trabecular meshwork cells to laser trabeculoplasty as shown by our group,24
was expressed in the trabecular meshwork library (see Trabecular Meshwork Gene listing online). Endogenous production of interleukin-1ß by glaucomatous trabecular meshwork cells also appears to protect the cells from responding to oxidative stress by induction of apoptosis.45
The cytoskeletal proteins may also affect aqueous outflow. Several pharmacologic agents that cause changes in cytoskeletal structure in trabecular meshwork cells are used clinically to increase outflow facility.46
47
Several cytoskeleton proteins, including
-smooth muscle actin,
1 actin, three isoforms of myosin, and vinculin were expressed in our trabecular meshwork library. Expression of
-smooth muscle actin has previously been demonstrated in trabecular meshwork organ culture and cells.48
49
50
Fibronectin, also highly expressed in our library, has been known to be a major component of trabecular meshwork extracellular matrix.51 52 Increased fibronectin deposition in the aqueous outflow pathway has been shown to occur in elderly and glaucomatous eyes,51 although a recent study found no differences between normal and glaucomatous eyes.53 The potential for fibronectin to influence the flow of aqueous humor through the juxtacanalicular trabecular meshwork and the inner walls of Schlemms canal has intrigued many glaucoma researchers over the years.51 52 53 54 55 56 57
Another abundant gene expressed in the trabecular meshwork was GAPDH, which is known for its role in glycolysis and oxidative phosphorylation. Considering that glycolysis is the major energy pathway for the trabecular meshwork,58 expression of the glycolytic enzymes would be expected. However, although high levels of GAPDH transcript were found, other genes for glycolytic enzymes were expressed at lower levels: glucose-6-phosphate dehydrogenase and enolase 1, each of which had two clones compared with seven clones for GAPDH. Once considered a housekeeping protein, many new functions for GAPDH have been ascribed, including membrane, cytoplasmic and nuclear functions in endocytosis, mRNA regulation, tRNA export, DNA replication, and DNA repair.59 Thus, the presence of GAPDH in our cDNA library may reflect additional roles for GAPDH in the trabecular meshwork in addition to glycolysis.
Comparison of Genes Highly Represented in Cell Line and Organ Culture Human Trabecular Meshwork cDNA Libraries
Four genes were highly expressed in both the organ culture library reported by Gonzalez et al.23
and our cell culture human trabecular meshwork cDNA library. These include ferritin L, translation elongation factor 1-
, GAPDH, and TIMP1. Approximately 25% of the transcripts were shared between the two libraries. Glycolysis provides the major source of energy to the trabecular meshwork; thus, high levels of GAPDH would be expected in both human trabecular meshwork cDNA libraries.58
The high levels of translation elongation factor 1-
in both cDNA libraries suggests that translational control may be an important method for regulating gene expression in the trabecular meshwork.
Primary cultured cells and organ cultures each have their unique advantages and disadvantages. One advantage of using primary cultured cells is that more cells can be obtained, thus allowing RNA work without need for amplification. In addition, the cells can be frozen for storage and thus are readily available for experimentation, whereas experiments with organ cultures are dependent on the supply of eyes. Because the trabecular meshwork cells have been isolated, changes occurring within these cells are solely a result of the trabecular meshworks physiology and are not influenced by adjacent tissues. However, some limitations of the cell culture system do exist. One of these is that mechanical forces acting on the outflow pathway tissue are not present in traditional cell culture. In addition, changes in gene expression may occur in cultured cells that do not reflect in vivo conditions. Organ cultures are probably a closer approximation of what is actually happening in the eye, because this model preserves the architecture of the outflow tissue. However, a limited amount of tissue necessitates amplification of the isolated message. Thus, the resultant library may not accurately reflect actual levels of specific messages, because some may be amplified better than others. Both primary cultured cells and organ cultures have unique advantages and disadvantages that must be taken into consideration in analysis of resultant data. Analysis of the two systems will give a much fuller picture of what is actually occurring in vivo, then either one alone could do.
Additional research is needed to generate a comprehensive profile of genes expressed in the trabecular meshwork during development and aging. The study reported herein and another recent publication23 provide a comprehensive reference point and an important resource of cloned "trabecular meshwork-expressed genes" that can be used for biological and functional investigations. Expression and chromosomal localization of trabecular meshwork ESTs should facilitate identification of mutations that result in or contribute to glaucoma.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication March 5, 2002; revised July 12, 2002; accepted July 23, 2002.
Commercial relationships policy: F.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Mary K. Wirtz, Department of Ophthalmology, Casey Eye Institute, Oregon Health and Sciences University, 3375 SW Terwilliger Boulevard, Portland, OR 97201-4197; wirtzm{at}ohsu.edu.
| References |
|---|
|
|
|---|
Invest Ophthalmol Vis Sci 41,422-430This article has been cited by other articles:
![]() |
I. Michael, M. Shmoish, D. S. Walton, and S. Levenberg Interactions between Trabecular Meshwork Cells and Lens Epithelial Cells: A Possible Mechanism in Infantile Aphakic Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3981 - 3987. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xue, N. Comes, and T. Borras Presence of an Established Calcification Marker in Trabecular Meshwork Tissue of Glaucoma Donors Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3184 - 3194. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xue, R. Wallin, E. A. Olmsted-Davis, and T. Borras Matrix GLA Protein Function in Human Trabecular Meshwork Cells: Inhibition of BMP2-Induced Calcification Process. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 997 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Fautsch, K. G. Howell, A. M. Vrabel, M. C. Charlesworth, D. C. Muddiman, and D. H. Johnson Primary Trabecular Meshwork Cells Incubated in Human Aqueous Humor Differ from Cells Incubated in Serum Supplements Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2848 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Liton, X. Liu, W. D. Stamer, P. Challa, D. L. Epstein, and P. Gonzalez Specific Targeting of Gene Expression to a Subset of Human Trabecular Meshwork Cells Using the Chitinase 3-Like 1 Promoter Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 183 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gonzalez, M. Caballero, P. B. Liton, W. D. Stamer, and D. L. Epstein Expression Analysis of the Matrix GLA Protein and VE-Cadherin Gene Promoters in the Outflow Pathway Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1389 - 1395. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |